CYLD mutations in familial skin appendage tumours

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Medical Genetics

• Publication date

  2008-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmg.2007.056127PMID 18234730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.

  2008influential reference
• A novel missense mutation in the CYLD gene in a Spanish family with multiple familial trichoepithelioma.

  2007cited by this paper
• Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

  2007cited by this paper
• A novel mutation of CYLD in a Chinese family with multiple familial trichoepithelioma and no CYLD protein expression in the tumour tissue

  2007cited by this paper
• Faculty Opinions recommendation of Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.

  2006cited by this paper
• Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.

  2006cited by this paper
• A case of Brooke–Spiegler syndrome with a new mutation in the CYLD gene

  2006cited by this paper
• CYLD mutations underlie Brooke–Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes

  2006cited by this paper
• Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.

  2005cited by this paper
• The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7*

  2005cited by this paper
• Two novel CYLD gene mutations in Chinese families with trichoepithelioma and a literature review of 16 families with trichoepithelioma reported in China

  2005cited by this paper
• Multiple Familial Trichoepithelioma Caused by Mutations in the Cylindromatosis Tumor Suppressor Gene

  2004cited by this paper
• Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD*

  2004cited by this paper
• Case of the Brooke–Spiegler syndrome

  2004cited by this paper
• CYLD mutation causes multiple familial trichoepithelioma in three Chinese families

  2004cited by this paper
• Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene

  2004cited by this paper
• Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma.

  2004cited by this paper
• Identification of a recurrent mutation in the CYLD gene in Brooke–Spiegler syndrome

  2003cited by this paper
• Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB

  2003cited by this paper
• Faculty Opinions recommendation of CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.

  2003cited by this paper
• Faculty Opinions recommendation of Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.

  2003cited by this paper
• A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.

  2003cited by this paper
• CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members

  2003cited by this paper
• The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

  2003cited by this paper
• Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages.

  2002cited by this paper
• Malignant transformation of multiple dermal cylindromas

  2001cited by this paper
• Identification of the familial cylindromatosis tumour-suppressor gene

  2000influential reference
• Multiple malignant cylindromas of skin in association with basel cell adenocarcinoma with adenoid cystic features of minor salivary gland

  1997influential reference
• The gene for multiple familial trichoepithelioma maps to chromosome 9p21.

  1996cited by this paper
• The clinicopathological features of familial cylindromas and trichoepitheliomas (Brooke‐Spiegler syndrome): a report of two families

  1992cited by this paper

• CYLD Cutaneous Syndrome: Report of a New Splicing Pathogenic Variant and Additional Evidence Supporting the Absence of Genotype-Phenotype Correlation.

  2026cites this paper
• Brooke–Spiegler Syndrome With Simultaneous Occurrence of Cylindroma, Spiradenoma, and Trichoepithelioma: A Rare Case With Malignant Progression

  2025cites this paper
• A case of an eccrine spiradenoma in an elderly patient mimicking an epidermoid cyst

  2025cites this paper
• Truncating CYLD pathogenic variants in CYLD cutaneous syndrome distinctly influence CYLD proteostasis and NF-κB signaling.

  2025cites this paper
• Multiple Trichoepithelioma Syndrome: A Case Report

  2023influential citation
• Giant Vascular Cylindroma in a Case of Brooke-Spiegler Syndrome

  2022cites this paper
• Multiple familial trichoepithelioma

  2022cites this paper
• Giant vascular eccrine spiradenoma; A rare entity with review of literature

  2022cites this paper
• Pediatric Surgical Pathology of Head and Neck Skin Lesions

  2021cites this paper
• Genetic Testing in CYLD Cutaneous Syndrome: An Update

  2021cites this paper
• Management of multiple trichoepithelioma: A review of pharmacological therapies

  2021cites this paper
• TACG_A_288274 427..444

  2021cites this paper
• Metastasierendes Zylindrokarzinom beim Brooke‐Spiegler‐Syndrom ‐ Fallbericht und Literaturübersicht

  2021cites this paper
• Multiple familial trichoepitheliomas: Ultrasonographic findings

  2020cites this paper
• Brooke-Spiegler syndrome.

  2020cites this paper
• Brooke–Spiegler Syndrome

  2020cites this paper
• CYLD Cutaneous Syndrome

  2020cites this paper
• Observations on Four Cases of Brooke–Spiegler Syndrome

  2020cites this paper
• CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus–Associated Head and Neck Cancers

  2020cites this paper
• Metastatic cylindrocarcinoma in Brooke‐Spiegler Syndrome – Report of a case and review of the literature

  2020cites this paper
• Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission

  2019cites this paper
• A large family with CYLD cutaneous syndrome: medical genetics at the community level

  2019cites this paper
• Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.

  2019cites this paper
• Multiple Nonfamilial Unilateral Trichoepitheliomas: Report of a Case—Mini Review of the Literature

  2019cites this paper
• Other Genetic Disorders Predisposing to Malignancy

  2019cites this paper
• Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression

  2018cites this paper
• Multiple Familial Trichoepithelioma.

  2018cites this paper
• miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.

  2018cites this paper
• Functional Relevance of Deubiquitinases in Life and Disease

  2017cites this paper
• Multiple Facial Trichoepitheliomas and Vulval Cysts: Extending the Phenotypic Spectrum in CYLD Cutaneous Syndrome

  2017cites this paper
• The p38/CYLD Pathway is Involved in Necroptosis Induced by Oxygen-glucose Deprivation Combined with ZVAD in Primary Cortical Neurons

  2017cites this paper
• An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region

  2017cites this paper
• Development and validation of LC–MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors

  2017cites this paper
• Implicación de CYLD en la homeostasis y tumorigénesis de piel y en el envejecimiento

  2017cites this paper
• Circulating Peptidome and Tumor-Resident Proteolysis.

  2017cites this paper
• SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes

  2016cites this paper
• Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors.

  2016cites this paper
• Genetic, haplotype and functional investigations on rare monogenic diseases

  2016cites this paper
• Immunohistology and Molecular Studies of Sweat Gland Tumors

  2016cites this paper
• The cylindromatosis (CYLD) gene and head and neck tumorigenesis

  2016cites this paper
• Brooke-Spiegler Syndrome and Phenotypic Variants: An Update

  2016cites this paper
• Phenotype-genotype correlations for clinical variants caused by CYLD mutations.

  2015cites this paper
• Knowledge explosion for monogenic skin diseases

  2015cites this paper
• Salivary Gland Diseases

  2015cites this paper
• Report of Three Novel Germline CYLD Mutations in Unrelated Patients with Brooke-Spiegler Syndrome, Including Classic Phenotype, Multiple Familial Trichoepitheliomas and Malignant Transformation

  2015cites this paper
• tamoxifen. Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK

  2015cites this paper
• Molecular basis of hypohidrotic ectodermal dysplasia: an update

  2015cites this paper
• Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway

  2015cites this paper
• Roles of linear ubiquitinylation, a crucial regulator of NF‐κB and cell death, in the immune system

  2015cites this paper
• A novel CYLD germline mutation in Brooke‐Spiegler syndrome

  2015cites this paper
• CYLD GeneticTesting for Brooke-Spiegler Syndrome, Familial Cylindromatosis and Multiple Familial Trichoepitheliomas

  2015cites this paper
• Large Germline Deletions of the CYLD Gene in Patients With Brooke–Spiegler Syndrome and Multiple Familial Trichoepithelioma

  2014cites this paper
• New insights into the biological role of COMMD1

  2014cites this paper
• TNFR1-activated NF-κB signal transduction: regulation by the ubiquitin/proteasome system.

  2014cites this paper
• Multiple familial trichoepithelioma: report of a Chinese family not associated with a mutation in the CYLD gene and CYLD protein expression in the trichoepithelioma tumor tissue

  2014cites this paper
• Herpes zoster duplex bilateralis symmetricus in an immunocompetent subject

  2014cites this paper
• Germline mutation analysis in the CYLD gene in Chinese patients with multiple trichoepitheliomas.

  2014cites this paper
• New insights into the biological role of COMMD 1 Bartuzi , Paulina

  2014cites this paper
• Identification of novel tumor suppressor proteases by degradome profiling of colorectal carcinomas

  2013cites this paper
• Tuning NF-κB activity: a touch of COMMD proteins.

  2013cites this paper
• Functional inactivation of CYLD promotes the metastatic potential of tumor epidermal cells.

  2013cites this paper
• Novel and Recurrent Germline and Somatic Mutations in a Cohort of 67 Patients From 48 Families With Brooke–Spiegler Syndrome Including the Phenotypic Variant of Multiple Familial Trichoepitheliomas and Correlation With the Histopathologic Findings in 379 Biopsy Specimens

  2013cites this paper
• A Clinicopathologic and Molecular Biologic Study of Patients Presenting With Few Adnexal Tumors (Two to Four) From the Morphological Spectrum of Brooke–Spiegler Syndrome

  2013cites this paper
• [Multiple familial trichoepithelioma: a new CYLD gene mutation].

  2013cites this paper
• Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes.

  2013cites this paper
• A novel germline mutation in the CYLD gene in a Slovak patient with Brooke-Spiegler syndrome.

  2013cites this paper
• The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.

  2012cites this paper
• Brooke‐Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor‐suppressor genes

  2012cites this paper
• A novel mutation of CYLD in a Chinese family with multiple familial trichoepithelioma

  2012cites this paper
• Deubiquitinases in cancer: new functions and therapeutic options

  2012cites this paper
• Blaschkoid distribution of cylindromas in a germline CYLD mutation carrier

  2012cites this paper
• Unravelling cylindromas : a molecular dissection of CYLD defective tumours

  2011cites this paper
• Genetic Diseases that Predispose to Malignancy

  2011cites this paper
• Recurrent CYLD nonsense mutation associated with a severe, disfiguring phenotype in an African American family with multiple familial trichoepithelioma.

  2011cites this paper
• Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

  2011cites this paper
• NF-κB and cancer: a paradigm of Yin-Yang.

  2011cites this paper
• Multiple (Familial) Trichoepitheliomas: A Clinicopathological and Molecular Biological Study, Including CYLD and PTCH Gene Analysis, of a Series of 16 Patients

  2011cites this paper
• Dysregulated TRK Signalling is a Therapeutic Target in CYLD Defective Tumours

  2011cites this paper
• Deubiquitinases in the regulation of NF-κB signaling

  2011cites this paper
• Transition from cylindroma to spiradenoma in CYLD‐defective tumours is associated with reduced DKK2 expression

  2011cites this paper
• Brooke-Spiegler Syndrome: Report of 10 Patients From 8 Families With Novel Germline Mutations: Evidence of Diverse Somatic Mutations in the Same Patient Regardless of Tumor Type

  2010cites this paper
• An Unusual Case of Turban Tumor Syndrome Treated With Total Scalp Excision and Advancement Flap and Skin Graft Reconstruction

  2010cites this paper
• Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis

  2010cites this paper
• Tumor and Stem Cell Biology Cancer Research The Deubiquitinating Enzyme USP 17 Is Highly Expressed in Tumor Biopsies , Is Cell Cycle Regulated , and Is Required for G 1S Progression

  2010cites this paper
• The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.

  2010cites this paper
• CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes

  2010cites this paper
• 33 – Tumors of cutaneous appendages

  2010cites this paper
• Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.

  2009cites this paper
• DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors

  2009cites this paper
• Skin type spiradenoma of the parotid gland with malignant transformation: report of a case with analysis of the CYLD gene.

  2009influential citation
• Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.

  2009cites this paper
• Multiple trichoepitheliomas – a novel mutation in the CYLD gene

  2009cites this paper
• Update of cylindromatosis gene (CYLD) mutations in Brooke‐Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling

  2009cites this paper
• Bazex-Dupré-Christol syndrome: an ectodermal dysplasia with skin appendage neoplasms.

  2009cites this paper
• Brooke–Spiegler syndrome complicated by unilateral hearing loss

  2008cites this paper
• Mutational analyses of the tumor suppressor gene PATCHED1 : Role in non-melanoma skin cancer and nevoid basal cell carcinoma

  2008cites this paper